Investigational Site Number : 3920003

Sunto-gun, Shizuoka 411-8777

0 studies enrolling now · 3 studies all time

What they study most

Non-squamous Non-small Cell Lung Cancer, Plasma Cell Myeloma

Studies at this site

• A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — Completed
• Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
• Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA — Stopped early